Annals of Pediatric Endocrinology & Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Seungah Lee, Dong Yun Lee

Ann Pediatr Endocrinol Metab. 2017;22(1):15-26. Published online March 31, 2017
DOI: https://doi.org/10.6065/apem.2017.22.1.15

Efficacy and safety of high‐dose glucagon‐like peptide‐1, glucagon‐like peptide‐1/glucose‐dependent insulinotropic peptide, and glucagon‐like peptide‐1/glucagon receptor agonists in type 2 diabetes

Christophe E. M. De Block, Eveline Dirinck, Ann Verhaegen, Luc F. Van Gaal

Diabetes, Obesity and Metabolism. 2022;24(5):788-805

Link1 Link2 Link3

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

Deborah Hinnen

Diabetes Spectrum. 2017;30(3):202-210

Glucagon-like peptide-1 receptor agonists

Baptist Gallwitz

Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Seungah Lee, Dong Yun Lee

Annals of Pediatric Endocrinology & Metabolism. 2017;22(1):15

Link1 Link2 Link3

Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists

Qiuhe Ji

Clinical Therapeutics. 2017;39(6):1244-1264

Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development

Bo Ahrén

Journal of Diabetes Investigation. 2018;10(2):196-201

WITHDRAWN: Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes

Julie A. Lovshin

Canadian Journal of Diabetes. 2017;

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes

Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich

Diabetes mellitus. 2017;20(4):286-298

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists

Alan J. Garber

Diabetes Care. 2011;34(Supplement_2):S279-S284

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

Hyun Jin Kim

The Journal of Korean Diabetes. 2018;19(1):35

Link1 Link2 Link3